Health Care M&A Deals, September 4, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.

The largest deal of the week is Nestle Health Science‘s acquisition of Aimmune Therapeutics, Inc. for $2.6 billion. Nestle Health Science is acquiring Aimmune Therapeutics through its wholly-owned subsidiary, Societe des Produits Nestle S.A. The acquisition is an extension of Nestle Health Science’s food allergy portfolio, creating a broader spectrum of solutions for children living with food allergies.

To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.

Click here to view our quarterly and annual publications and here to view our monthly webinar series.